Home | FREE Subscription | Latest News | Archive | Offsite Newswires

Commercial


FDA Approves New Indication for ertapenem for the Treatment of Moderate to Severe Complicated Foot Infection in Diabetics
FDA has approved INVANZ® (ertapenem), a once-daily injectable antibiotic, for the treatment of moderate to severe complicated foot infection due to indicated pathogens in diabetic patients without osteomyelitis.
Posted on November 15, 2005 - 2:05am.
Read Full News Article

Sponsored Link
Link below features a Diabetic News advertiser/sponsor:

Offsite Sponsored Links
Links below are not controlled by The Diabetic News: